Rise in incidence of sports-related injuries, supportive government initiatives

By -

 Rise in incidence of sports-related injuries, supportive government initiatives, and increase in awareness about physical fitness are anticipated toboost the growth of the global sports medicine devices market. 

The report offers an extensive analysis of the changing trends, key market segments, drivers and opportunities, competitive landscape, top investment pockets among others. According to the report, the global sports medicine devices market accrued $7.17 billion in 2017 and is expected to reach $12.73 billion by 2025, growing at a CAGR of 7.3% from 2018 to 2025.

Rise in incidence of sports-related injuries, increase in awareness about physical fitness, and supportive government initiatives drive the growth of the industry. However, dearth of skilled professionals and lack of guidance on appropriate administration of sports medicines hinder the market growth. On the other hand, surge in demand for minimally invasive surgeries would create new opportunities for the market players in near future.

Knee injury segment to remain lucrative through 2025 

The knee injury segment accounted for about one-fourth of the total market share in 2017 and will maintain its lion’s share throughout the forecast period. This segment would register the fastest CAGR of 8.6% from 2018 to 2025. As knee injury is one of the most common injuries a sportsperson is prone to, this segment offers lucrative prospects for the market during the forecast period. The other applications analyzed in the study include hand wrist injury, shoulder injury, ankle foot injury, arm elbow injury, back spine injury, and hip groin injury.

North America to dominate in terms of revenue by 2025 

North America contributed nearly half of the total market share in 2017, owing to early adoption of advanced sports medicine devices in the region. This segment will remain dominant throughout the forecast period. However, Asia-Pacific would grow at the fastest CAGR of 12.2% from 2018 to 2025, owing to the rapidly changing healthcare infrastructure in developing nations including India and China, rise in awareness among people regarding fitness, and significant increase in the number of athletes.

Torchbearers of the market 

The report analyzes key market players namely, Smith & Nephew Plc, Johnson & Johnson (Depuy Mitek), Stryker Corporation, Conmed Corporation, Arthrex, Inc., Breg, Inc., Zimmer Biomet Holdings, Inc., DJO Global, Inc., Mueller Sports Medicine, Inc., and Wright Medical Group N.V. These players have adopted various strategies such as mergers & acquisitions, partnerships, expansions, collaborations, joint ventures, and others to attain a strong foothold in the industry.

Comments

Post a Comment

Popular posts from this blog

Global Cancer pain market is segmented based on drug type, disease indication, and region.

By -
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Read more

U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

By -
Image
  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Read more